DooPrime DePu Capital: Morgan Stanley’s Q3 Earnings Shine, Stock Surges ~7% to a New All-Time High

Industry Updates | On October 16, Morgan Stanley released its third-quarter financial results, reporting net revenue of $15.38 billion. Key financial metrics—and revenues from all three major divisions—Wealth Management, Trading, and Investment Banking—exceeded expectations, driving the firm’s stock price higher and setting a new all-time high. On the same day, the UK announced its September CPI data—the first time in three and a half years that inflation fell below the central bank’s target; Gevo secured $1.46 billion in financing, sending its share price soaring nearly 52%. UK CPI Falls Below Central Bank Target for First Time in Three and a Half Years According to data released by the UK Office for National Statistics, the September CPI rose 1.7% year-on-year—down sharply from the previous reading of 2.2% and below the consensus forecast of 1.9%. This decline was driven by substantial drops in airfare and gasoline prices, alongside a marked slowdown in services-sector inflation. At 1.7%, the CPI hit its lowest level since April 2021 and, for the first time, dipped below the Bank of England’s 2% target. As a result, traders increased bets on an interest-rate cut by the Bank of England this year, now expecting a 24-basis-point reduction in November—up from a prior expectation of 21 basis points. Gevo Secures $1.46 Billion Financing, Shares Surge Nearly 52% Gevo, a renewable chemicals and biofuels company, announced it had received a conditional loan guarantee of $1.46 billion from the U.S. Department of Energy’s Loan Programs Office to support its Net-Zero 1 project in South Dakota. Designed to produce sustainable aviation fuel (SAF), the Net-Zero 1 project aims to achieve net-zero carbon emissions over the fuel’s full life cycle—including emissions from combustion. Following this announcement, Gevo’s U.S.-listed shares surged nearly 52% in after-hours trading. Morgan Stanley’s Key Financial Metrics and Divisional Revenues All Exceed Expectations Morgan Stanley reported third-quarter net revenue of $15.38 billion—well above the expected $14.35 billion. Revenues from its Wealth Management, Institutional Securities, and Investment Management divisions all surpassed forecasts. Key highlights from Morgan Stanley’s Q3 performance: ・Net revenue of $15.38 billion, exceeding the estimated $14.35 billion and up approximately 16% year-on-year from $13.273 billion in Q3 2023; ・Pre-tax profit of $4.221 billion, up 34% year-on-year; ・Earnings per share (EPS) of $1.88, surpassing the expected $1.59; ・Wealth Management net revenue of $7.27 billion, up 14% year-on-year and above the estimated $6.88 billion; ・Institutional Securities net revenue of $6.815 billion, up approximately 20% from $5.669 billion in Q3 2023; ・Investment Management net revenue of $1.455 billion, up approximately 9% from $1.336 billion in Q3 2023. Several favorable factors contributed to Morgan Stanley’s strong Q3 results: robust market activity—which boosted its large-scale wealth management business; a rebound in investment banking activity following 2023; and strong trading volumes. Ted Pick, Morgan Stanley’s CEO, stated in the press release: “Against the backdrop of a favorable environment across our global businesses, the firm delivered strong performance in the third quarter.”

Global and China Bio-Butanol Market Outlook and Dynamic Analysis Report, 2025–2031

7 Global Market Size by Region and Growth Potential in Emerging Markets 7.1 Global Bio-Butanol Sales Volume and Revenue 7.1.1 Global Bio-Butanol Revenue (2020–2031) 7.1.2 Global Bio-Butanol Sales Volume (2020–2031) 7.1.3 Global Bio-Butanol Price Trends (2020–2031) 7.2 Market Size Analysis of Major Global Regions: 2020 vs. 2024 vs. 2031 7.2.1 Regional Bio-Butanol Revenue and Market Share (2020–2025) 7.2.2 Regional Bio-Butanol Revenue Forecast (2026–2031) 7.3 Sales Volume Analysis of Major Global Regions: 2020 vs. 2024 vs. 2031 7.3.1 Regional Bio-Butanol Sales Volume and Market Share (2020–2025) 7.3.2 Regional Bio-Butanol Sales Volume and Market Share Forecast (2026–2031) 7.4 Current Traditional Market Analysis 7.5 Future Emerging Market Analysis (Economic Development, Policy Environment, Operational Costs) 7.5.1 ASEAN Countries 7.5.2 Russia 7.5.3 Eastern Europe 7.5.4 Mexico & Brazil 7.5.5 Middle East 7.5.6 North Africa 7.6 Distribution and Market Share of Key Potential Market Players 8 Profiles of Major Global Producers 8.1 Gevo 8.1.1 Gevo: Company Overview, Bio-Butanol Production Facilities, Sales Regions, Competitors, and Market Position 8.1.2 Gevo Bio-Butanol Product Specifications, Parameters, and Applications 8.1.3 Gevo Bio-Butanol Sales Volume, Revenue, Pricing, and Gross Margin (2020–2025) 8.1.4 Gevo Company Profile and Core Business Activities 8.1.5 Gevo’s Latest Corporate Developments 8.2 Godavari Biorefineries 8.2.1 Godavari Biorefineries: Company Overview, Bio-Butanol Production Facilities, Sales Regions, Competitors, and Market Position 8.2.2 Godavari Biorefineries Bio-Butanol Product Specifications, Parameters, and Applications 8.2.3 Godavari Biorefineries Bio-Butanol Sales Volume, Revenue, Pricing, and Gross Margin (2020–2025) 8.2.4 Godavari Biorefineries Company Profile and Core Business Activities 8.2.5 Godavari Biorefineries’ Latest Corporate Developments 9 Product-Type Segmentation Analysis 9.1 Product Classification by Type 9.1.1 Bio-n-Butanol 9.1.2 Bio-Isobutanol 9.2 Comparative Analysis of Global Bio-Butanol Revenue by Product Type (2020 vs. 2024 vs. 2031) 9.3 Global Bio-Butanol Sales Volume by Product Type (2020–2031)

Gevo Q3 2026 Earnings Date and Estimates

Oct 13, 2026

Gevo Inc. will report its Q3 2026 earnings on November 9, 2026, after market close. Analysts forecast earnings of $0.04 per share on revenue of $55.92 million, up significantly from the previous year.

MarketBeat

2026-04-02

Gevo Appoints Key Executive Team Members

2026-04-02

Insider Selling: Gevo (NASDAQ:GEVO) COO Sells $276,000 in Stock

2026-04-02

Andrew Shafer, Chief Customer Marketing & Brand Officer at Gevo, Sells $15k in Shares

2026-04-05

GEVO Valuation Analysis: Undervalued by Nearly 47%

2026-04-07

Gevo Inc Stock: Why Sustainable Fuels Make It a Long-Term Watch